Improving Noninvasive Colorectal Cancer Screening
Abstract
This editorial discusses the evolution and effectiveness of noninvasive colorectal cancer screening methods, including guaiac based tests, fecal immunochemical testing (FIT), multitarget stool DNA tests, and cell-free DNA blood-based assays. It highlights recent studies (BLUE-C and ECLIPSE) that demonstrate improved sensitivity and specificity, aiming to increase screening adherence and reduce colorectal cancer mortality.